Assuntos
Humanos , Masculino , Feminino , Diagnóstico por Imagem/métodos , Imageamento por Ressonância Magnética/métodos , Cardiomiopatia Hipertrófica Familiar/diagnóstico por imagem , Prognóstico , Volume Sistólico , Ecocardiografia/métodos , Epidemiologia , Fatores de Risco , Função Ventricular , Morte Súbita Cardíaca , Eletrocardiografia/métodos , Fibrose Endomiocárdica , Insuficiência Cardíaca , MiocárdioRESUMO
OBJECTIVE: The toxicity of anti-cancer chemotherapeutic agents can be reduced by associating these compounds, such as the anti-proliferative agent paclitaxel, with a cholesterol-rich nanoemulsion (LDE) that mimics the lipid composition of low-density lipoprotein (LDL). When injected into circulation, the LDE concentrates the carried drugs in neoplastic tissues and atherosclerotic lesions. In rabbits, atherosclerotic lesion size was reduced by 65% following LDE-paclitaxel treatment. The current study aimed to test the effectiveness of LDE-paclitaxel on inpatients with aortic atherosclerosis. METHODS: This study tested a 175 mg/m2 body surface area dose of LDE-paclitaxel (intravenous administration, 3/3 weeks for 6 cycles) in patients with aortic atherosclerosis who were aged between 69 and 86 yrs. A control group of 9 untreated patients with aortic atherosclerosis (72-83 yrs) was also observed. RESULTS: The LDE-paclitaxel treatment elicited no important clinical or laboratory toxicities. Images were acquired via multiple detector computer tomography angiography (64-slice scanner) before treatment and at 1-2 months after treatment. The images showed that the mean plaque volume in the aortic artery wall was reduced in 4 of the 8 patients, while in 3 patients it remained unchanged and in one patient it increased. In the control group, images were acquired twice with an interval of 6-8 months. None of the patients in this group exhibited a reduction in plaque volume; in contrast, the plaque volume increased in three patients and remained stable in four patients. During the study period, one death unrelated to the treatment occurred in the LDE-paclitaxel group and one death occurred in the control group. CONCLUSION: Treatment with LDE-paclitaxel was tolerated by patients with cardiovascular disease and showed the potential to reduce atherosclerotic lesion size.
Assuntos
Doenças da Aorta/tratamento farmacológico , Aterosclerose/tratamento farmacológico , Colesterol/uso terapêutico , Nanopartículas/uso terapêutico , Paclitaxel/uso terapêutico , Moduladores de Tubulina/uso terapêutico , Idoso , Idoso de 80 Anos ou mais , Angiografia , Aorta Torácica/efeitos dos fármacos , Doenças da Aorta/diagnóstico por imagem , Aterosclerose/diagnóstico por imagem , Colesterol/sangue , Sistemas de Liberação de Medicamentos , Emulsões Gordurosas Intravenosas/uso terapêutico , Feminino , Humanos , Masculino , Tomografia Computadorizada Multidetectores , Reprodutibilidade dos Testes , Fatores de Tempo , Resultado do Tratamento , Triglicerídeos/sangueRESUMO
OBJECTIVE: The toxicity of anti-cancer chemotherapeutic agents can be reduced by associating these compounds, such as the anti-proliferative agent paclitaxel, with a cholesterol-rich nanoemulsion (LDE) that mimics the lipid composition of low-density lipoprotein (LDL). When injected into circulation, the LDE concentrates the carried drugs in neoplastic tissues and atherosclerotic lesions. In rabbits, atherosclerotic lesion size was reduced by 65% following LDE-paclitaxel treatment. The current study aimed to test the effectiveness of LDE-paclitaxel on inpatients with aortic atherosclerosis. METHODS: This study tested a 175 mg/m2 body surface area dose of LDE-paclitaxel (intravenous administration, 3/3 weeks for 6 cycles) in patients with aortic atherosclerosis who were aged between 69 and 86 yrs. A control group of 9 untreated patients with aortic atherosclerosis (72-83 yrs) was also observed. RESULTS: The LDE-paclitaxel treatment elicited no important clinical or laboratory toxicities. Images were acquired via multiple detector computer tomography angiography (64-slice scanner) before treatment and at 1-2 months after treatment. The images showed that the mean plaque volume in the aortic artery wall was reduced in 4 of the 8 patients, while in 3 patients it remained unchanged and in one patient it increased. In the control group, images were acquired twice with an interval of 6-8 months. None of the patients in this group exhibited a reduction in plaque volume; in contrast, the plaque volume increased in three patients and remained stable in four patients. During the study period, one death unrelated to the treatment occurred in the LDE-paclitaxel group and one death occurred in the control group. CONCLUSION: Treatment with LDE-paclitaxel was tolerated by patients with cardiovascular disease and showed the potential to reduce atherosclerotic lesion size.
Assuntos
Humanos , Masculino , Feminino , Idoso , Idoso de 80 Anos ou mais , Doenças da Aorta/tratamento farmacológico , Colesterol/uso terapêutico , Paclitaxel/uso terapêutico , Aterosclerose/tratamento farmacológico , Moduladores de Tubulina/uso terapêutico , Nanopartículas/uso terapêutico , Aorta Torácica/efeitos dos fármacos , Doenças da Aorta/diagnóstico por imagem , Fatores de Tempo , Triglicerídeos/sangue , Angiografia , Colesterol/sangue , Reprodutibilidade dos Testes , Resultado do Tratamento , Sistemas de Liberação de Medicamentos , Aterosclerose/diagnóstico por imagem , Emulsões Gordurosas Intravenosas/uso terapêutico , Tomografia Computadorizada MultidetectoresRESUMO
BACKGROUND: The diagnostic accuracy of 64-slice MDCT in comparison with IVUS has been poorly described and is mainly restricted to reports analyzing segments with documented atherosclerotic plaques. OBJECTIVES: We compared 64-slice multidetector computed tomography (MDCT) with gray scale intravascular ultrasound (IVUS) for the evaluation of coronary lumen dimensions in the context of a comprehensive analysis, including segments with absent or mild disease. METHODS: The 64-slice MDCT was performed within 72 h before the IVUS imaging, which was obtained for at least one coronary, regardless of the presence of luminal stenosis at angiography. A total of 21 patients were included, with 70 imaged vessels (total length 114.6 ± 38.3 mm per patient). A coronary plaque was diagnosed in segments with plaque burden > 40%. RESULTS: At patient, vessel, and segment levels, average lumen area, minimal lumen area, and minimal lumen diameter were highly correlated between IVUS and 64-slice MDCT (p < 0.01). However, 64-slice MDCT tended to underestimate the lumen size with a relatively wide dispersion of the differences. The comparison between 64-slice MDCT and IVUS lumen measurements was not substantially affected by the presence or absence of an underlying plaque. In addition, 64-slice MDCT showed good global accuracy for the detection of IVUS parameters associated with flow-limiting lesions. CONCLUSIONS: In a comprehensive, multi-territory, and whole-artery analysis, the assessment of coronary lumen by 64-slice MDCT compared with coronary IVUS showed a good overall diagnostic ability, regardless of the presence or absence of underlying atherosclerotic plaques.
Assuntos
Doença da Artéria Coronariana/diagnóstico por imagem , Endossonografia/métodos , Tomografia Computadorizada Multidetectores/métodos , Placa Aterosclerótica/diagnóstico por imagem , Idoso , Vasos Coronários/diagnóstico por imagem , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Background: The diagnostic accuracy of 64-slice MDCT in comparison with IVUS has been poorly described and is mainly restricted to reports analyzing segments with documented atherosclerotic plaques. Objectives: We compared 64-slice multidetector computed tomography (MDCT) with gray scale intravascular ultrasound (IVUS) for the evaluation of coronary lumen dimensions in the context of a comprehensive analysis, including segments with absent or mild disease. Methods: The 64-slice MDCT was performed within 72 h before the IVUS imaging, which was obtained for at least one coronary, regardless of the presence of luminal stenosis at angiography. A total of 21 patients were included, with 70 imaged vessels (total length 114.6 ± 38.3 mm per patient). A coronary plaque was diagnosed in segments with plaque burden > 40%. Results: At patient, vessel, and segment levels, average lumen area, minimal lumen area, and minimal lumen diameter were highly correlated between IVUS and 64-slice MDCT (p < 0.01). However, 64-slice MDCT tended to underestimate the lumen size with a relatively wide dispersion of the differences. The comparison between 64-slice MDCT and IVUS lumen measurements was not substantially affected by the presence or absence of an underlying plaque. In addition, 64-slice MDCT showed good global accuracy for the detection of IVUS parameters associated with flow-limiting lesions. Conclusions: In a comprehensive, multi-territory, and whole-artery analysis, the assessment of coronary lumen by 64-slice MDCT compared with coronary IVUS showed a good overall diagnostic ability, regardless of the presence or absence of underlying atherosclerotic plaques. .
Fundamento: A comparação do rigor diagnóstico da TCMD e da USIV foi pouco descrita, estando restrita principalmente a estudos que avaliaram segmentos com placas ateroscleróticas já documentadas. Objetivos: Este estudo objetiva avaliar o desempenho diagnóstico da tomografia computadorizada com 64 colunas de detectores (tomografia computadorizada multidetector- TCMD) e da ultrassonografia intravascular (USIV) em escala de cinza na verificação das dimensões da luz coronária, em um contexto mais amplo, incluindo também segmentos coronários sadios e com patologia leve. Métodos: A TCMD foi realizada em todos os pacientes antes da realização da USIV, com um intervalo < 72 horas entre os dois exames. Imagens de USIV foram obtidas de pelo menos uma coronária, independente da presença de estenose luminal durante a angiografia. Um total de 21 pacientes foram incluídos, com imagens de 70 vasos (comprimento total 114,6 ± 38.3 mm por paciente). Placas coronárias foram diagnosticada em segmentos com carga de placas > 40%. Resultados: Uma alta correlação entre as medidas de TCMD e USIV para área luminar média, área luminar mínima e diâmetro luminar mínimo foi encontrada no nível de paciente, vaso e segmento (p-valor < 0,01 para todas as correlações). A TCMD, no entanto, tendeu a subestimar o tamanho luminar com uma dispersão de diferenças relativamente ampla. A comparação entre as medidas da luz por TCMD e USIV não foi substancialmente afetada pela presença ou ausência de placa subjacente. Além disso, a TCMD mostrou boa precisão geral na detecção de parâmetros associados a lesões limitantes de fluxo. Conclusão: Em uma análise compreensiva e multi-focal da luz coronária, demonstramos bom desempenho diagnóstico da TCMD, quando comparada a USIV, independente da presença de placas ateroscleróticas adjacentes. .
Assuntos
Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doença da Artéria Coronariana , Doença da Artéria Coronariana , Endossonografia/métodos , Tomografia Computadorizada Multidetectores/métodos , Placa Aterosclerótica , Placa Aterosclerótica , Vasos Coronários , Vasos CoronáriosAssuntos
Feminino , Humanos , Masculino , Doenças Cardiovasculares/diagnóstico , Imageamento por Ressonância Magnética/normas , Tomografia Computadorizada por Raios X/normas , Angiocardiografia/métodos , Angiocardiografia/normas , Brasil , Imageamento por Ressonância Magnética/métodos , Valor Preditivo dos Testes , Prognóstico , Sociedades Médicas , Tomografia Computadorizada por Raios X/métodosAssuntos
Doenças Cardiovasculares/diagnóstico , Imageamento por Ressonância Magnética/normas , Tomografia Computadorizada por Raios X/normas , Angiocardiografia/métodos , Angiocardiografia/normas , Brasil , Feminino , Humanos , Imageamento por Ressonância Magnética/métodos , Masculino , Valor Preditivo dos Testes , Prognóstico , Sociedades Médicas , Tomografia Computadorizada por Raios X/métodosRESUMO
BACKGROUND: Myocardial fibrosis (MF) occurs in up to 80% of subjects with asymptomatic or mildly symptomatic hypertrophic cardiomyopathy (HCM) and can constitute an arrhythmogenic substrate for re-entrant, life-threatening ventricular arrhythmias in predisposed persons. OBJECTIVE: The aim was to investigate whether MF detected by delayed enhancement cardiac CT is predictive of ventricular tachycardia (VT) and fibrillation (VF) that require appropriate therapy by an implantable cardioverter defibrillator (ICD) in patients with HCM. METHODS: Twenty-six patients with HCM with previously (for at least 1 year) implanted ICD underwent MF evaluation by cardiac CT. MF was quantified by myocardial delayed enhanced cardiac CT. Data on ICD firing were recorded every 3 months after ICD implantation. Risk factors for sudden cardiac death in patients with HCM were evaluated in all patients. RESULTS: MF was present in 25 of 26 patients (96%) with mean fibrosis mass of 20.5 ± 15.8 g. Patients with appropriate ICD shocks for VF/VT had significantly greater MF mass than patients without (29.10 ± 19.13 g vs 13.57 ± 8.31 g; P = .01). For a MF mass of at least 18 g, sensitivity and specificity for appropriate ICD firing were 73% (95% CI, 49%-88%) and 71% (95% CI, 56%-81%), respectively. Kaplan-Meier curves indicated a significantly greater VF/VT event rate in patients with MF mass ≥18 g than in patients with MF <18 g (P = .02). In the Cox regression analysis, the amount of MF was independently associated with VF/VT in ICD-stored electrograms. CONCLUSION: The mass of MF detected by cardiac CT in patients with HCM at high risk of sudden death was associated with appropriate ICD firings.
Assuntos
Cardiomiopatia Hipertrófica/complicações , Cardiomiopatia Hipertrófica/terapia , Desfibriladores Implantáveis , Fibrose Endomiocárdica/diagnóstico por imagem , Taquicardia Ventricular/diagnóstico por imagem , Taquicardia Ventricular/etiologia , Fibrilação Ventricular/diagnóstico por imagem , Fibrilação Ventricular/etiologia , Adolescente , Adulto , Meios de Contraste , Fibrose Endomiocárdica/fisiopatologia , Feminino , Humanos , Iopamidol , Masculino , Valor Preditivo dos Testes , Modelos de Riscos Proporcionais , Estudos Prospectivos , Curva ROC , Interpretação de Imagem Radiográfica Assistida por Computador , Fatores de Risco , Taquicardia Ventricular/fisiopatologia , Fibrilação Ventricular/fisiopatologiaRESUMO
A avaliação funcional de pacientes com suspeita de doença arterial coronária é fundamental para definir a gravidade do prognóstico e por decidir sobre a necessidade ou não de realizar procedimentos de revascularização percutâneous ou cirúrgicos. Por outro lado, a busca pelo componente anatômico permite definir o diagnóstico de aterosclerose coronária e deve ser, portanto, valorizada. A avaliação da anatomia pode-se limitar a pesquisa de aterosclerose, comprometendo territórios extracoronários, em especial as artérias carótidas. Este objetivo pode ser alcançado com o uso de tecnologias, tais como o ultrassom e a ressonância magnética. Contudo, a identificação de ateroslcerose coronária indica casos de maior gravidade e parece ter melhor relação com a incidência de eventos cardíacos adversos. Desta forma, a análise daqueles vasos tem sido alvo de grande interesse. Duas tecnologias têm-se destacado. A quantificação do escore de cálcio por meio da tomografia computadorizada sem o uso de meio de contraste. que é particularemnte útil em casos de assintomáticos, com risco pré-teste intermediário, sem eventos prévios e sem evidências de isquemia miocárdica. A angiotomografia contrastada, por sua vez, tem agregado valor à estratificação clínica do risco e tem valor em especial em casos com sintomas atípicos, equivalentes isquêmicos e no caso da presença de exames não invasivos conflitantes. Particular destaque merece o elevado poder preditivo negativo deste exame e a possibilidade que ele oferece de excluir a presença de doença coronária com elevado grau de certeza. Estes exames, em associação com os fatores de risco convencionais e com os exames funcionais, têm aprimorado o manejo de pacientes com suspeita de apresentar doença arterial coronária.
Functional evaluation of patients with suspected coronary artery disease is a key element in patients with suspected coronarb artery disease, particularly to define revascularization strategies. Anatomical evaluation, on the other hand, may add important information for it warrants the diagnosis of coronary atherosclerosis and may indicate cases of worse prognosis. For that purpose, the identification of atherosclerosis in any arterial territory may add prognostic. Particularly carotid arteries ultrasound evaluation has potential clinical use. On the other hand, evaluation of the coronary arteries may be even more clinically useful. Coronary artery calcium score with no contrast computed tomography has proven to contribute to that end, moreover in an asymptomatic patient at intermediate pretest risk. For patients with equivocal symptoms, clinical features or noninvasive tests presenting results that could be caused by coronary artery disease, contrast enhanced computed tomograhy is a better choice. This test has a high negative predictive value and may add important data to risk stratification and should be taken into account when evaluating selected subset of patients at risk for presenting coronary artery disease, often in association with clinical data, labs tests results and functional evaluation.
Assuntos
Humanos , Aterosclerose/complicações , Doença das Coronárias/complicações , Doença das Coronárias/diagnóstico , Tomografia Computadorizada por Raios X/métodos , Tomografia Computadorizada por Raios X , Cálcio/análise , Fatores de RiscoRESUMO
FUNDAMENTO: A redução da frequência cardíaca (FC) na angiografia por tomografia das artérias coronarianas (ATCCor) é fundamental para a qualidade de imagem. A eficácia dos bloqueadores de cálcio como alternativas para pacientes com contraindicações aos betabloqueadores não foi definida. OBJETIVOS: Comparar a eficácia na redução da FC e variabilidade RR do metoprolol e diltiazem na ATCCor. MÉTODOS: Estudo prospectivo, randomizado, aberto, incluiu pacientes com indicação clínica de ATCCor, em ritmo sinusal, com FC>70bpm e sem uso de agentes que interferissem com a FC. Cinquenta pacientes foram randomizados para grupos: metoprolol IV 5-15 mg ou até FC≤60 bpm(M), e diltiazem IV 0,25-0,60mg/kg ou até FC≤60 bpm (D). Pressão arterial (PA) e FC foram aferidas na condição basal, 1min, 3min e 5min após agentes, na aquisição e após ATCCor. RESULTADOS: A redução da FC em valores absolutos foi maior no grupo M que no grupo D (1, 3, 5min, aquisição e pós-exame). A redução percentual da FC foi significativamente maior no grupo M apenas no 1 min e 3 min após início dos agentes. Não houve diferença no 5 min, durante a aquisição e após exame. A variabilidade RR percentual do grupo D foi estatisticamente menor do que a do grupo M durante a aquisição (variabilidade RR/ FC média da aquisição). Um único caso de BAV, 2:1 Mobitz I, revertido espontaneamente ocorreu (grupo D). CONCLUSÃO: Concluímos que o diltiazem é uma alternativa eficaz e segura aos betabloqueadores na redução da FC na realização de angiografia por tomografia computadorizada das artérias coronarianas. (Arq Bras Cardiol. 2012; [online].ahead print, PP.0-0).
BACKGROUND: Reducing heart rate (HR) in CT angiography of the coronary arteries (CTACor) is critical to image quality. The effectiveness of calcium channel blockers as alternatives for patients with contraindications to beta-blockers has not been established. OBJECTIVES: To compare the efficacy in the reduction of HR and RR variability of metoprolol and diltiazem in CTACor. METHODS: Prospective, randomized, open study that included patients with clinical indication of CTACor in sinus rhythm with HR > 70 bpm and no use of agents that could interfere with HR. Fifty patients were randomized to the groups: metoprolol IV 5-15 mg or up to HR ≤ 60 bpm (M), and diltiazem IV 0.25 to 0.60 mg/kg or up to HR ≤ 60 bpm (D). Blood pressure (BP) and HR were measured at baseline, 1 minute, 3 minutes and 5 minutes after the agents, at the acquisition and after CTACor. RESULTS: HR reduction in absolute values was higher in group M than in group D (1, 3, 5 min, acquisition and post-test). The percentage reduction of HR was significantly higher in group M only 1 min and 3 min after the start of the agents. There was no difference in 5 min at acquisition and after examination. The percentage RR variability in group D was lower than that in group M during acquisition (RR variability/mean HR of acquisition). A single case of AVB, 2:1 Mobitz I occurred, which was spontaneously reverted (group D). CONCLUSION: We conclude that diltiazem is an effective and safe alternative to beta-blockers in the reduction of HR when performing computed tomography angiography of coronary arteries. (Arq Bras Cardiol. 2012; [online].ahead print, PP.0-0).
Assuntos
Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Bloqueadores dos Canais de Cálcio/farmacologia , Angiografia Coronária/métodos , Diltiazem/farmacologia , Frequência Cardíaca/efeitos dos fármacos , Tomografia Computadorizada por Raios X/métodos , Antagonistas de Receptores Adrenérgicos beta 1 , Pressão Sanguínea/efeitos dos fármacos , Metoprolol , Estudos Prospectivos , Reprodutibilidade dos Testes , Estatísticas não Paramétricas , Fatores de TempoRESUMO
BACKGROUND: Reducing heart rate (HR) in CT angiography of the coronary arteries (CTACor) is critical to image quality. The effectiveness of calcium channel blockers as alternatives for patients with contraindications to beta-blockers has not been established. OBJECTIVES: To compare the efficacy in the reduction of HR and RR variability of metoprolol and diltiazem in CTACor. METHODS: Prospective, randomized, open study that included patients with clinical indication of CTACor in sinus rhythm with HR > 70 bpm and no use of agents that could interfere with HR. Fifty patients were randomized to the groups: metoprolol IV 5-15 mg or up to HR ≤ 60 bpm (M), and diltiazem IV 0.25 to 0.60 mg/kg or up to HR ≤ 60 bpm (D). Blood pressure (BP) and HR were measured at baseline, 1 minute, 3 minutes and 5 minutes after the agents, at the acquisition and after CTACor. RESULTS: HR reduction in absolute values was higher in group M than in group D (1, 3, 5 min, acquisition and post-test). The percentage reduction of HR was significantly higher in group M only 1 min and 3 min after the start of the agents. There was no difference in 5 min at acquisition and after examination. The percentage RR variability in group D was lower than that in group M during acquisition (RR variability/mean HR of acquisition). A single case of AVB, 2:1 Mobitz I occurred, which was spontaneously reverted (group D). CONCLUSION: We conclude that diltiazem is an effective and safe alternative to beta-blockers in the reduction of HR when performing computed tomography angiography of coronary arteries.
Assuntos
Bloqueadores dos Canais de Cálcio/farmacologia , Angiografia Coronária/métodos , Diltiazem/farmacologia , Frequência Cardíaca/efeitos dos fármacos , Tomografia Computadorizada por Raios X/métodos , Antagonistas de Receptores Adrenérgicos beta 1 , Pressão Sanguínea/efeitos dos fármacos , Contraindicações , Feminino , Humanos , Masculino , Metoprolol , Pessoa de Meia-Idade , Estudos Prospectivos , Reprodutibilidade dos Testes , Estatísticas não Paramétricas , Fatores de TempoRESUMO
A pesquisa da viabilidade miocárdica ainda é um importante aspecto da avaliação de pacientes com suspeita de apresentar doença arterial coronaria e, também, no planejamento do tratamento de diversos subgrupos de pacientes. Diversas técnicas não invasivas são utilizadas neste sentido, com sucesso, mas ainda não existem dados definitivos sobre a superioridade relativa destes exames. A tomografia computadorizada por múltiplos detectores, por outro lado, apresenta potencial de ser empregada neste sentido, pois o exame apresenta elevada resolução espacial e é usado de modo efetivo como parte da investigação incruenta de pacientes com suspeita de doença arterial coronária. Duas técnicas são disponíveis atualmente: uma objetiva avaliar o grau de opacificação da parede miocárdica na fase arterial do fluxo de contraste. Outro protocolo tenta determinar a presença de realce tardio, a exemplo do que é feito pela ressonância magnética. Diferentes trabalhos sugerem que ambas podem ser utilizadas com eficácia e que poderia até complementar a investigação destes casos. O progresso do conhecimento e da tecnologia permite também fazer estas imagens com segurança crescente. Trabalhos adicionais são necessários para determinar o real papel da tomografia neste cenário, mas os resultados preliminares são animadores.
Assuntos
Humanos , Infarto do Miocárdio/complicações , Infarto do Miocárdio/diagnóstico , Tomografia Computadorizada de Emissão/métodos , Tomografia Computadorizada de Emissão , Vasos Coronários/cirurgiaRESUMO
A 69-year-old female patient presented heart failure with preserved ejection fraction and atrial fibrillation. Echocardiography and late gadolinium enhancement magnetic resonance imaging were suggestive of endomyocardial fibrosis (EMF). The patient underwent cardiac surgery, and after surgery, she developed low cardiac output syndrome and died. Postmortem examination revealed residual fibrosis of the left ventricle (LV), mild endocardial fibrous deposition of the right ventricle, and severe concentric, symmetrical LV hypertrophy. Histological examination of the surgically resected material from the LV confirmed EMF. Histopathology of the interventricular septum disclosed myocardial hypertrophy and disarray plus fine interstitial fibrosis, typical of hypertrophic cardiomyopathy. The present case illustrates the association of two different patterns of cardiomyopathies in the same patient.
Assuntos
Fibrilação Atrial/diagnóstico , Cardiomiopatia Hipertrófica/diagnóstico , Fibrose Endomiocárdica/diagnóstico , Insuficiência Cardíaca/diagnóstico , Idoso , Fibrilação Atrial/complicações , Fibrilação Atrial/fisiopatologia , Baixo Débito Cardíaco/etiologia , Cardiomiopatia Hipertrófica/complicações , Cardiomiopatia Hipertrófica/cirurgia , Fibrose Endomiocárdica/complicações , Fibrose Endomiocárdica/cirurgia , Evolução Fatal , Feminino , Insuficiência Cardíaca/complicações , Insuficiência Cardíaca/cirurgia , Ventrículos do Coração/patologia , Humanos , Miocárdio/patologia , Complicações Pós-OperatóriasRESUMO
BACKGROUND: Myocardial stress CT perfusion (CTP) can detect myocardial ischemia. OBJECTIVE: We evaluated the transmural perfusion ratio (TPR) of dipyridamole stress CTP to detect significant coronary stenosis (>70%) defined by quantitative invasive coronary angiography (ICA). METHODS: Twenty-six patients (61.6 ± 8.0 years old; 14 males), without prior myocardial infarction, with positive single-photon emission computed tomography (SPECT; <2 months) and clinical indication for ICA, underwent a customized multidetector-row CT (MDCT) protocol with rest/stress myocardial perfusion evaluation and coronary CT angiography. TPR was defined as mean subendocardial divided by mean subepicardial attenuation and quantified on rest and stress MDCT images. Abnormal TPR was defined as 2 SDs below the mean rest TPR. RESULTS: All 26 patients completed the CT protocol with no adverse events. Rest TPR was measured in all patients with a mean of 1.06 ± 0.11, and abnormal TPR was considered <0.85. For 6 patients with normal coronary arteries by ICA, the mean TPR of territories with a previous positive perfusion defect in SPECT was 1.02 ± 0.18 (95% CI, 0.86-1.18; n = 6), and mean TPR of territories without perfusion defect in SPECT was 1.03 ± 0.09 (95% CI, -0.95 to 1.11; n = 12; P = 0.83). Mean stress TPR in territories with positive SPECT and significant coronary artery disease by quantitative ICA was 0.71 ± 0.13 (95% CI, -0.64 to 0.77) and in the remote myocardial was 1.01 ± 0.09 (95% CI, -0.96 to 1.06; P < 0001). In these territories, a significant Pearson's correlation was observed (r = -0.74, P < 0.001). CONCLUSION: TPR has a good correlation with SPECT and ICA to detect significant coronary stenosis.
Assuntos
Circulação Coronária , Estenose Coronária/diagnóstico por imagem , Dipiridamol , Imagem de Perfusão do Miocárdio/métodos , Tomografia Computadorizada por Raios X , Vasodilatadores , Idoso , Brasil , Angiografia Coronária , Estenose Coronária/fisiopatologia , Feminino , Hemodinâmica , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Prognóstico , Estudos Prospectivos , Índice de Gravidade de Doença , Tomografia Computadorizada de Emissão de Fóton ÚnicoRESUMO
BACKGROUND: Endocardial fibrous tissue (FT) deposition is a hallmark of endomyocardial fibrosis (EMF). Echocardiography is a first-line and the standard technique for the diagnosis of this disease. Although late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) allows FT characterization, its role in the diagnosis and prognosis of EMF has not been investigated. METHODS AND RESULTS: Thirty-six patients (29 women; age, 54±12 years) with EMF diagnosis after clinical evaluation and comprehensive 2-dimensional Doppler echocardiography underwent cine-CMR for assessing ventricular volumes, ejection fraction and mass, and LGE-CMR for FT characterization and quantification. Indexed FT volume (FT/body surface area) was calculated after planimetry of the 8 to 12 slices obtained in the short-axis view at end-diastole (mL/m(2)). Surgical resection of FT was performed in 16 patients. In all patients, areas of LGE were confined to the endocardium, frequently as a continuous streak from the inflow tract extending to the apex, where it was usually most prominent. There was a relation between increased FT/body surface area and worse New York Heart Association functional class and with increased probability of surgery (P<0.05). The histopathologic examination of resected FT showed typical features of EMF with extensive endocardial fibrous thickening, proliferation of small vessels, and scarce inflammatory infiltrate. In multivariate analysis, the patients with FT/body surface area >19 mL/m(2) had an increased mortality rate, with a relative risk of 10.8. CONCLUSIONS: Our study provides evidence that LGE-CMR is useful in the diagnosis and prognosis of EMF through quantification of the typical pattern of FT deposition.
Assuntos
Meios de Contraste , Fibrose Endomiocárdica/diagnóstico , Gadolínio DTPA , Imageamento por Ressonância Magnética , Adulto , Idoso , Fibrose Endomiocárdica/complicações , Fibrose Endomiocárdica/patologia , Fibrose Endomiocárdica/fisiopatologia , Feminino , Insuficiência Cardíaca/complicações , Ventrículos do Coração/patologia , Humanos , Processamento de Imagem Assistida por Computador , Imagem Cinética por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Prognóstico , Volume SistólicoRESUMO
Durante a última década, os avanços tecnológicos na área de tomografia computadorizada e ressonância magnética fizeram com que ambas as técnicas adquirissem papel central na avaliação da aorta, sendo considerados exames de escolha no diagnóstico das doenças da aorta. Desta maneira, a avaliação da aorta torácica com o tomógrafo com múltiplos detectores permitiu uma aquisição rápida das imagens da aorta (poucos segundos). Por outro lado, a tecnologia dos aparelhos de ressonância magnética de alto campo (1,5 Tesla ou maior) associada ao desenvolvimento de novas sequências de pulso permitiu uma excelente e precisa avaliação da aorta, sem radiação ionizante, entretanto com um tempo de aquisição maior quando comparada à tomografia. Assim, atualmente tanto a tomografia computadorizada como a ressonância magnética podem ser utilizados com precisão na investigação das doenças da aorta, seja no diagnóstico ou acompanhamento dos aneurismas, dissecção, úlceras e/ou hematomas intramurais.
In the last decade, technological advances in computed tomography and magnetic resonance images, have turned both techniques into the main role in aorta evaluation that are considered choice exams in the diagnosis of aortic diseases.Currently, aorta thoracic evaluation by multiple detectors computed tomography scanners can be performed in a fast acquisition of images (few seconds). Moreover, the use of magnetic resonance with high-field (1.5 Tesla or greater) and the development of new sequences, allowed an excellent and accurate assessment of the aorta, without ionizing radiation.Both computed tomography and magnetic resonance imaging can be used accurately in the evaluation of aortic diseases, either in diagnosis or follow up of aneurysms, dissections, ulcers and / or intramural hematomas.
Assuntos
Humanos , Masculino , Feminino , Adulto , Aorta Torácica/cirurgia , Espectroscopia de Ressonância Magnética/métodos , Tomografia/métodos , TomografiaRESUMO
A cardiomiopatia hipertrófica (CMH) é uma doença cardíaca genética e se caracteriza como a principal causadora de morte súbita em jovens, com apresentação clínica variável, desde assintomáticos a morte súbita, o que dificulta sua estratificação de risco. Tanto a ressonância magnética cardiovascular (RMC) como a tomografia computadorizada com múltiplos detectores (TCMD) mostraram-se capazes de avaliar a fibrose miocárdica, que é frequentemente encontrada nos casos de CMH. Os objetivos desta tese são: avaliar a distribuição e a correlação entre as áreas de hipertrofia e fibrose miocárdica pela RMC em pacientes com CMH; comparar a avaliação da fibrose miocárdica pela TCMD com a avaliação da fibrose miocárdica pela RMC; avaliar a fibrose miocárdica pela TCMD em pacientes com CMH portadores de cardiodesfibriladores e correlacionar a fibrose miocárdica pela TCMD com as arritmias ventriculares com terapia apropriada pelo CDI. Foram selecionados 145 pacientes com CMH, dos quais 13 apresentaram critérios de exclusão, sendo, portanto, incluídos 132 pacientes em seguimento ambulatorial, que assinaram termo de consentimento livre e esclarecido. Destes, 91 pacientes foram submetidos à RMC para avaliação das características morfofuncionais do coração, incluindo a caracterização da fibrose miocárdica. Outros 15 pacientes foram submetidos tanto à TCMD quanto à RMC para avaliação e comparação da fibrose miocárdica por ambos os métodos. Finalmente, 26 pacientes hipertróficos portadores de CDI foram submetidos somente à TCMD para a avaliação da fibrose miocárdica e seguimento. Entre os 91 pacientes submetidos à RMC, a idade média foi de 37,9±17 anos, dos quais 58% eram homens. A média da espessura máxima da maior parede hipertrofiada do VE foi de 24,2±6,3mm e a média da FEVE, de 73,3±13,3%. A fibrose miocárdica foi observada em 76,9% dos 91 pacientes com uma média da massa de fibrose indexada pela superfície corpórea de 8,1±11,0g/m2. Dos 1547 segmentos miocárdicos...
Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disorder leading cause of sudden death in young people with extremely variable presentation, from asymptomatic to sudden death as first symptom, leads to challenging risk stratification. Recently, both cardiovascular magnetic resonance (CMR) and multidetector computed tomography (MDCT) were able to assess myocardial fibrosis (MF) often found in cases of HCM. Our objectives were to evaluate the distribution and correlation of myocardial hypertrophy (MH) and myocardial fibrosis by CMR in patients with HCM; to compare and validate the assessment of myocardial fibrosis by MDCT and CMR and to evaluate the correlation between myocardial fibrosis by MDCT and ventricular arrhythmias appropriately treated by defibrillators, due to contraindications to CMR in this group. 145 HCM patients were selected with 13 having exclusion criteria. Then 132 outpatients were included and signed informed consent for this study. First, 91 patients were submitted to CMR to evaluate the morphofunctional characteristics of the heart including myocardial fibrosis; Second, 15 patients were submitted to both MDCT and CMR in order to evaluate myocardial fibrosis by both methods, and finally 26 HCM patients with implantable cardiac defibrillator (ICD) were submitted to MDCT, for assessment MF. Among 91 patients submitted to CMR the mean age was 37.9 ± 17 years old, and 58% were men. The LV maximum end diastolic wall thickness was 24.2 ± 6.3mm and LVEF mean was 73.3% ± 13.3. MF was evident in 76.9% of patients with a mean fibrosis mass index of 8.1±11.0g/m2. Of all the 1547 myocardial segments from 91 HCM patient, 35.2% of segments with MF occurred in segments without MH, 58.6% of MH segments had no signs of MF. Linear regression showed no significant correlation between number of segments with MH and MF (r = 0.13, p = 0.21). A per patient Kappa analysis showed no significant agreement (Kappa0.40, p ns) between MH and MF in 65.8%...
Assuntos
Humanos , Masculino , Feminino , Adulto , Cardiomiopatia Hipertrófica , Fibrose , Espectroscopia de Ressonância Magnética , Prognóstico , Tomografia Computadorizada por Raios XRESUMO
Recently, stress myocardial computed tomographic perfusion (CTP) was shown to detect myocardial ischemia. Our main objective was to evaluate the feasibility of dipyridamole stress CTP and compare it to single-photon emission computed tomography (SPECT) to detect significant coronary stenosis using invasive conventional coronary angiography (CCA; stenosis >70%) as the reference method. Thirty-six patients (62 +/- 8 years old, 20 men) with previous positive results with SPECT (<2 months) as the primary inclusion criterion and suspected coronary artery disease underwent a customized multidetector-row CT protocol with myocardial perfusion evaluation at rest and during stress and coronary CT angiography (CTA). Multidetector-row computed tomography was performed in a 64-slice scanner with dipyridamole stress perfusion acquisition before a second perfusion/CT angiographic acquisition at rest. Independent blinded observers performed analysis of images from CTP, CTA, and CCA. All 36 patients completed the CT protocol with no adverse events (mean radiation dose 14.7 +/- 3.0 mSv) and with interpretable scans. CTP results were positive in 27 of 36 patients (75%). From the 9 (25%) disagreements, 6 patients had normal coronary arteries and 2 had no significant stenosis (8 false-positive results with SPECT, 22%). The remaining patient had an occluded artery with collateral flow confirmed by conventional coronary angiogram. Good agreement was demonstrated between CTP and SPECT on a per-patient analysis (kappa 0.53). In 26 patients using CCA as reference, sensitivity, specificity, and positive and negative predictive values were 88.0%, 79.3%, 66.7%, and 93.3% for CTP and 68.8, 76.1%, 66.7%, and 77.8%, for SPECT, respectively (p = NS). In conclusion, dipyridamole CT myocardial perfusion at rest and during stress is feasible and results are similar to single-photon emission CT scintigraphy. The anatomical-perfusion information provided by this combined CT protocol may allow identification of false-positive results by SPECT.